2024 annual financial data
Stoke Therapeutics 2024 Net margin
Direct answer
Net margin was -243.42%.
Operating income was -101,372,000 USD and net income was -88,981,000 USD.
Operating cash flow was -86,851,000 USD.
Get free Stoke Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 36,555,000 USD
- Operating income
- -101,372,000 USD
- Net income
- -88,981,000 USD
- Operating cash flow
- -86,851,000 USD